These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 18925424)

  • 21. Quantitative gene-expression of the tumor angiogenesis markers vascular endothelial growth factor, integrin alphaV and integrin beta3 in human neuroendocrine tumors.
    Oxboel J; Binderup T; Knigge U; Kjaer A
    Oncol Rep; 2009 Mar; 21(3):769-75. PubMed ID: 19212638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RhoC is essential for angiogenesis induced by hepatocellular carcinoma cells via regulation of endothelial cell organization.
    Wang W; Wu F; Fang F; Tao Y; Yang L
    Cancer Sci; 2008 Oct; 99(10):2012-8. PubMed ID: 19016761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
    Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
    J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paracrine action of sFLT-1 secreted by stably-transfected Ehrlich ascites tumor cells and therapy using sFLT-1 inhibits ascites tumor growth in vivo.
    Ramachandra S; D'Souza SS; Gururaj AE; Shaila MS; Salimath BP
    J Gene Med; 2009 May; 11(5):422-34. PubMed ID: 19266483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maspin expression, angiogenesis, prognostic parameters, and outcome in malignant melanoma.
    Chua R; Setzer S; Govindarajan B; Sexton D; Cohen C; Arbiser JL
    J Am Acad Dermatol; 2009 May; 60(5):758-66. PubMed ID: 19389518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
    Shibuya M
    FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone marrow-derived EP3-expressing stromal cells enhance tumor-associated angiogenesis and tumor growth.
    Ogawa Y; Suzuki T; Oikawa A; Hosono K; Kubo H; Amano H; Ito Y; Kitasato H; Hayashi I; Kato T; Sugimoto Y; Narumiya S; Watanabe M; Majima M
    Biochem Biophys Res Commun; 2009 May; 382(4):720-5. PubMed ID: 19318087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular imaging in drug development.
    Willmann JK; van Bruggen N; Dinkelborg LM; Gambhir SS
    Nat Rev Drug Discov; 2008 Jul; 7(7):591-607. PubMed ID: 18591980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic imaging of angiogenesis in vivo.
    Meining A; Wallace MB
    Gastroenterology; 2008 Apr; 134(4):915-8. PubMed ID: 18395072
    [No Abstract]   [Full Text] [Related]  

  • 32. Imaging of angiogenesis in cardiology.
    Higuchi T; Wester HJ; Schwaiger M
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34 Suppl 1():S9-19. PubMed ID: 17479264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiogenesis imaging in man: a personal view from the pharmaceutical industry.
    Dzik-Jurasz A
    Br J Radiol; 2003; 76 Spec No 1():S81-2. PubMed ID: 15456716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenesis imaging in the post-genomic era.
    Li KC
    Br J Radiol; 2003; 76 Spec No 1():S1-2. PubMed ID: 15456708
    [No Abstract]   [Full Text] [Related]  

  • 35. Angiogenesis imaging.
    Folkman J; Beckner K
    Acad Radiol; 2000 Oct; 7(10):783-5. PubMed ID: 11048875
    [No Abstract]   [Full Text] [Related]  

  • 36. Within-subject biological variation in disease: the case of tumour markers.
    Dittadi R; Peloso L; Gion M
    Ann Clin Biochem; 2008 Mar; 45(Pt 2):226-7; author reply 227. PubMed ID: 18325193
    [No Abstract]   [Full Text] [Related]  

  • 37. Vascular phenotyping of the invasive front in breast cancer using a 3D angiogenesis atlas.
    Bhargava A; Popel AS; Pathak AP
    Microvasc Res; 2023 Sep; 149():104555. PubMed ID: 37257688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Relationship Between UBE2C and AGGF1 Overexpression and Tumor Angiogenesis in Non-Small Cell Lung Cancer.
    Wang Y; Shi F; Tao R; Wu J; Gu J; Yang R; Wu S
    Cancer Manag Res; 2021; 13():5919-5930. PubMed ID: 34354374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in translational imaging of the microcirculation.
    Guerraty M; Bhargava A; Senarathna J; Mendelson AA; Pathak AP
    Microcirculation; 2021 Apr; 28(3):e12683. PubMed ID: 33524206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanotechnology for angiogenesis: opportunities and challenges.
    Kargozar S; Baino F; Hamzehlou S; Hamblin MR; Mozafari M
    Chem Soc Rev; 2020 Jul; 49(14):5008-5057. PubMed ID: 32538379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.